Picture of Merck & Co logo

MRK — Merck & Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Merck's eye disease drug meets main goal in trial

Merck's eye disease drug meets main goal in trial

- Merck MRK.N said on Thursday its drug met the main goal in a mid- to late-stage trial testing it in adult patients with a type of disease that affects blood vessels at the back of the eye.


(Reporting by Christy Santhosh in Bengaluru; Editing by Sahal Muhammed)

((Christy.Santhosh@thomsonreuters.com;))

Recent news on Merck & Co

See all news